Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis
{{output}}
Background: Asthma is a chronic disease characterized by airway hyperresponsiveness, inflammation and mucus production. In Type 2 asthma, two phenotypic components are often co-expressed (eosinophilic and allergic). Elevated biom... ...
